BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 26056734)

  • 21. Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chains.
    Xu Y; Sui W; Deng S; An G; Wang Y; Xie Z; Yao H; Zhu G; Zou D; Qi J; Hao M; Zhao Y; Wang J; Chen T; Qiu L
    Leuk Lymphoma; 2013 Jan; 54(1):123-32. PubMed ID: 22712834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay.
    Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA
    Pathology; 2015 Oct; 47(6):564-9. PubMed ID: 26352111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma].
    Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment.
    Morales-García LJ; Lillo Rodríguez RM; Pacheco-Delgado MS
    Clin Biochem; 2023 Aug; 118():110610. PubMed ID: 37429509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia.
    Morabito F; De Filippi R; Laurenti L; Zirlik K; Recchia AG; Gentile M; Morelli E; Vigna E; Gigliotti V; Calemma R; Amoroso B; Neri A; Cutrona G; Ferrarini M; Molica S; Del Poeta G; Tripodo C; Pinto A
    Blood; 2011 Dec; 118(24):6353-61. PubMed ID: 21998207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype.
    Scarpa R; Pulvirenti F; Pecoraro A; Vultaggio A; Marasco C; Ria R; Altinier S; Compagno N; Firinu D; Plebani M; De Carli M; Matucci A; Vianello F; Vacca A; Spadaro G; Quinti I; Agostini C; Milito C; Cinetto F
    Front Immunol; 2020; 11():319. PubMed ID: 32296413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression and significance of immunoglobulin free light chains in serum and lung tissues from patients with chronic obstructive pulmonary disease].
    Zhang M; Tao HC; Li YQ; Pei HS; Zhu SY; Chen B; Zhou RJ; Zhang MW
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):945-9. PubMed ID: 24503428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The clinical significance of serum free light chain in primary systemic amyloidosis].
    Zhai YP; Song P; Li F; Liu HN; Yu YP; Zhou XG; Shi P; An ZM; Zhou X; Zhang CN
    Zhonghua Nei Ke Za Zhi; 2011 May; 50(5):404-7. PubMed ID: 21624224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Test of Serum Free Light Chain and Its Clinical Significance in Light Chain Multiple Myeloma].
    Song P; An ZM; Zhou XG; Li F; Wang LP; Zhao Q; Yu YP; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1357-61. PubMed ID: 26524037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease.
    Martín-Nares E; Saavedra-González V; Fagundo-Sierra R; Santinelli-Núñez BE; Romero-Maceda T; Calderón-Vasquez K; Hernandez-Molina G
    Sci Rep; 2021 Jan; 11(1):1832. PubMed ID: 33469111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients.
    Henriot B; Rouger E; Rousseau C; Escoffre M; Sébillot M; Bendavid C; Minvielle S; Avet-Loiseau H; Decaux O; Moreau C
    Clin Chem Lab Med; 2019 Aug; 57(9):1397-1405. PubMed ID: 30973821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
    Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
    J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
    Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
    BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of serum free light chains in renal transplantation.
    Sánchez-Castañón M; Gago M; Fernandez-Fresnedo G; Gomez-Alamillo C; Ruiz-Criado J; Lopez-Hoyos M; Arias M
    Transplant Proc; 2010 Oct; 42(8):2861-3. PubMed ID: 20970552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument.
    Lutteri L; Aldenhoff MC; Cavalier E
    Clin Chim Acta; 2018 Dec; 487():161-167. PubMed ID: 30243748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplant.
    Fernando RC; Rizzatti EG; Braga WM; Santos MG; de Oliveira MB; Pestana JO; Baiocchi OC; Colleoni GW
    Leuk Lymphoma; 2013 Oct; 54(10):2177-80. PubMed ID: 23398208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
    Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
    J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties.
    Fabbrini P; Sirtori S; Casiraghi E; Pieruzzi F; Genovesi S; Corti D; Brivio R; Gregorini G; Como G; Carati ML; Viganò MR; Stella A
    Blood Purif; 2013; 35 Suppl 2():52-8. PubMed ID: 23676837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.